The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Brimica Genuair

AstraZeneca ABEU/1/14/963/001-003

Main Information

Trade NameBrimica Genuair
Active SubstancesMicronized formoterol fumarate dihydrate
Micronized aclidinium bromide
Dosage FormInhalation powder
Licence HolderAstraZeneca AB
Licence NumberEU/1/14/963/001-003

Group Information

ATC CodeR03AL Adrenergics in combination with anticholinergics
R03AL05 Adrenergics in combination with anticholinergics


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back